Bovine milk exosomes were modified with hyaluronic acid (HA), which targets CD44 overexpressed on tumors, and then loaded with Dox to form a new carrier (HA-mExo-Dox) that specifically targets CD44-positive tumor cells and allow tumor cells to efficiently take up Dox (Li et al., 2020). Here, CD44 is linked to neoplasm.